Literature DB >> 2052061

The long-term course of Lyme arthritis in children.

I S Szer1, E Taylor, A C Steere.   

Abstract

BACKGROUND AND METHODS: The natural history of Lyme disease is not completely known. We studied the long-term course of Lyme arthritis in 46 children in whom the onset of the disease occurred between 1976 and 1979 and who received no antibiotic therapy for at least the first four years of the illness.
RESULTS: Of the 46 children (age range, 2 to 15 years), 33 (72 percent) initially had erythema migrans, 7 (15 percent) had influenza-like symptoms, and 6 (13 percent) had migratory joint pain. These manifestations were followed by brief attacks of arthritis, particularly affecting the knee. The percentage of children with recurrent episodes of arthritis declined each year. By year 4, only 10 children still had a mean of two episodes of arthritis per year; the duration of arthritis was generally longer in older children (P less than 0.05). During the sixth year of illness, two children (4 percent) had keratitis, and more than 10 years after the onset of disease, a subtle encephalopathy developed in two other children. Of the 39 children whom we were able to contact in 1988-1989, 12 (31 percent) still had occasional brief episodes of joint pain and 1 (3 percent) had marked fatigue. All 46 children had positive IgG antibody responses to Borrelia burgdorferi throughout the illness and on long-term follow-up. As compared with those who became asymptomatic, the children with recurrent symptoms more often had IgM responses to the spirochete and had significantly higher IgG titers (P less than 0.05).
CONCLUSIONS: The course of initially untreated Lyme disease in children may include acute infection followed by attacks of arthritis and then by keratitis, subtle joint pain, or chronic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052061     DOI: 10.1056/NEJM199107183250304

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

Review 1.  Clinical manifestations of tick-borne infections in children.

Authors:  K A Bryant; G S Marshall
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

Review 2.  Infectious diseases and AIDS.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

3.  Atypical bilateral symmetric erosive chronic polyarthritis in the course of Lyme disease.

Authors:  J Gutiérrez; M Palermo; M C Maroto; M Abellan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

Review 4.  Management of childhood arthritis. Part 1: Acute arthritis.

Authors:  P N Malleson
Journal:  Arch Dis Child       Date:  1997-05       Impact factor: 3.791

5.  Ocular manifestations in children and adolescents with Lyme arthritis.

Authors:  H I Huppertz; D Münchmeier; W Lieb
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

6.  Child with 3-year history of joint pain and swelling.

Authors:  Kieran Michael Moore; Nicholas Papadomanolakis-Pakis; Julia Lew; Linna Li; Kirk Leifso
Journal:  Can Fam Physician       Date:  2020-11       Impact factor: 3.275

7.  Rational diagnosis and treatment in unclassified arthritis: how clinical data may guide requests for Lyme serology and antibiotic treatment.

Authors:  I Blaauw; B Dijkmans; P Bouma; S van der Linden
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

8.  2nd European Symposium on Lyme Borreliosis. A NATO advanced research workshop. United Kingdom, 19-20 May 1993. Abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

Review 9.  Experimental immunization against Lyme borreliosis with recombinant Osp proteins: an overview.

Authors:  A Sadziene; A G Barbour
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

10.  [Pediatric dermatology. New aspects of bacterial skin infections in children].

Authors:  H Hofmann; C Schnopp
Journal:  Hautarzt       Date:  2009-03       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.